January 8, 2010 – Japanese regulatory officials this week cleared the XIENCE V Everolimus-Eluting Coronary Stent ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
January 7, 2010 – Anti-platelet treat with Effient (prasugrel) compared with Plavix (clopidogrel) was more cost ...
January 07, 2010
January 5, 2010 – In vivo and in vitro data released yesterday shows a new bioresorbable stent platform allows for ...
January 05, 2010Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
January 4, 2010 – The first patient was enrolled the TAXUS Liberte arm of the Dual Anti-Platelet Therapy (DAPT) ...
January 04, 2010
December 8, 2009 – The first live U.K. cases involving Cappella’s self-expanding Sideguard Coronary Sidebranch ...
December 08, 2009November 18, 2009 – New, joint guidelines from the American College of Cardiology (ACC), the American Heart ...
November 19, 2009
Feature | Stephanie LaBelle, senior analyst, Millennium Research Group
In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – ...
November 18, 2009
Feature | Dave Fornell
Standard drug-eluting stent technology seemed to have taken a backseat at this year’s TCT as cardiologists look ...
November 17, 2009
November 17, 2009 – Following positive three-year data from the first 30 patients treated with a fully ...
November 17, 2009
November 10, 2009 – The latest data from seven studies focused on the treatment of peripheral arterial disease ...
November 10, 2009
November 10, 2009 – Clinically, stent fracture has been reported in 1-2 percent of patients after drug-eluting ...
November 10, 2009
November 3, 2009 – Boston Scientific Corp. yesterday said it received CE Mark for its PROMUS Element Everolimus ...
November 03, 2009
November 3, 2009 – Abbott yesterday said both the XIENCE PRIME Everolimus-Eluting Coronary Stent System and the ...
November 03, 2009
November 3, 2009 – The FDA said Boston Scientific recently changed the name of the company's Liberté Bare-Metal ...
November 02, 2009
October 27, 2009 – Interim six-month clinical results on the use of the FlexStent Femoropopliteal Self Expanding ...
October 26, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now